Cost-effectiveness of an emergency department-based early sepsis resuscitation protocol

Critical Care Medicine

Volumn 39, Issue 6, 2011, Pages 1306-1312

  Jones, Alan E ^a   Troyer, Jennifer L ^b   Kline, Jeffrey A ^a  

^a CAROLINAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

Author keywords

cost effectiveness; EGDT; emergency medicine; resuscitation; sepsis

Indexed keywords

ACTIVATED PROTEIN C; DOBUTAMINE; HYPERTENSIVE FACTOR;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL PROTOCOL; COST EFFECTIVENESS ANALYSIS; EMERGENCY CARE; EMERGENCY WARD; ENDOTRACHEAL INTUBATION; ERYTHROCYTE TRANSFUSION; FEMALE; HEALTH CARE COST; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RESUSCITATION; SEPSIS;

EID: 79957653360     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31821201be     Document Type: Article

References (31)

1. Angus D, Linde-Zwirble W, Lidicker J, et al: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310. (Pubitemid 32641789)
2. Dombrovskiy VY, Martin AA, Sunderram J, et al: Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003. Crit Care Med 2007; 35:1244-1250. (Pubitemid 46642649)
3. Wang HE, Shapiro NI, Angus DC, et al: National estimates of severe sepsis in United States emergency departments. Crit Care Med 2007; 35:1928-1936. (Pubitemid 47220368)
4. Rivers E, Nguyen B, Havstad S, et al: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377.
5. Jones AE, Focht A, Horton JM, et al: Prospective external validation of the clinical effectiveness of an emergency department-based early goal directed therapy protocol for severe sepsis and septic shock. Chest 2007; 132:425-432. (Pubitemid 47282372)
6. Trzeciak S, Dellinger RP, Abata NL, et al: Translating research to clinical practice: A 1-year experience with implementing early goal-directed therapy for septic shock in the emergency department. Chest 2006; 129: 225-232. (Pubitemid 43289838)
7. Shapiro NI, Howell MD, Talmor D, et al: Implementation and outcomes of the Multiple Urgent Sepsis Therapies (MUST) protocol. Crit Care Med 2006; 34:1025-1032.
8. Dellinger RP, Levy MM, Carlet JM, et al: Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36:296-327.
9. Jones AE, Kline JA: Use of goal-directed therapy for severe sepsis and septic shock in academic emergency departments. Crit Care Med 2005; 33:1888-1889.
10. Carlbom DJ, Rubenfeld GD: Barriers to implementing protocol-based sepsis resuscitation in the emergency department-Results of a national survey. Crit Care Med 2007; 35:2525-2535.
11. Puskarich MA, Marchick MR, Kline JA, et al: One year mortality of patients treated with an emergency department based early goal directed therapy protocol for severe sepsis and septic shock: A before and after study. Crit Care 2009; 13:R167.
12. Bone R, Balk R, Cerra F, et al: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/ Society of Critical Care Medicine. Chest 1992; 101:1644-1655.
13. Vincent JL, Moreno R, Takala J, et al: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/ failure. Intensive Care Med 1996; 22:707-710. (Pubitemid 26254283)
14. Quartin AA, Schein RM, Kett DH, et al: Magnitude and duration of the effect of sepsis on survival. Department of Veterans Affairs Systemic Sepsis Cooperative Studies Group. JAMA 1997; 277:1058-1063. (Pubitemid 27147544)
15. Lazosky A, Young GB, Zirul S, et al: Quality of life after septic illness. J Crit Care 2009; 25:406-412.
16. Sullivan PW, Lawrence WF, Ghushchyan V: A national catalog of preference-based scores for chronic conditions in the United States. Med Care 2005; 43:736-749. (Pubitemid 40993769)
17. Gold M, Siegel J, Russell L, et al: Cost-Effectiveness in Health and Medicine. First Edition. New York, Oxford University Press, 1996.
18. Drummond MF, O'Brien B, Stoddart GL, et al: Methods for the Economic Evaluation of Health Care Programmes. New York, Oxford University Press, 2000.
19. Hoch JS, Briggs AH, Willan AR: Something old, something new, something borrowed, something blue: A framework for the marriage of health econometrics and costeffectiveness analysis. Health Economics 2002; 11:415-430. (Pubitemid 34752613)
20. Stinnett AA, Mullahy J: Net health benefits: A new framework for the analysis of uncertainty in cost-effectiveness analysis. Medical Decision Making 1998; 18:S68-S80. (Pubitemid 28175944)
21. Braithwaite RS, Meltzer DO, King JT Jr, et al: What does the value of modern medicine say about the $50,000 per quality-adjusted lifeyear decision rule? Med Care 2008; 46: 349-356.
22. Angus DC, Musthafa AA, Clermont G, et al: Quality-adjusted survival in the first year after the acute respiratory distress syndrome. Am J Respir Crit Care 2001; 163:1389-1394. (Pubitemid 32506604)
23. Manns BJ, Lee H, Doig CJ, et al: An economic evaluation of activated protein C treatment for severe sepsis. N Engl J Med 2002; 347: 993-1000.
24. Fowler RA, Hill-Popper M, Stasinos J, et al: Cost-effectiveness of recombinant human activated protein C and the influence of severity of illness in the treatment of patients with severe sepsis. J Crit Care 2003; 18:181-194.
25. Talmor D, Greenberg D, Howell MD, et al: The costs and cost-effectiveness of an integrated sepsis treatment protocol. Crit Care Med 2008; 36:1168-1174. (Pubitemid 351482666)
26. Talmor D, Shapiro N, Greenberg D, et al: When is critical care medicine cost-effective? A systematic review of the cost-effectiveness literature. Crit Care Med 2006; 34:2738-2747. (Pubitemid 44610938)
27. Ubel PA, Hirth RA, Chernew ME, et al: What is the price of life and why doesn't it increase at the rate of inflation? Arch Intern Med 2003; 163:1637-1641. (Pubitemid 36898950)
28. Huang DT, Clermont G, Dremsizov TT, et al: Implementation of early goal-directed therapy for severe sepsis and septic shock: A decision analysis. Crit Care Med 2007; 35:1-12.
29. Shorr AF, Micek ST, Jackson WL Jr, et al: Economic implications of an evidence-based sepsis protocol: Can we improve outcomes and lower costs? Crit Care Med 2007; 35: 1257-1262. (Pubitemid 46642651)
30. Siegel JE, Weinstein MC, Russell LB, et al: Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996; 276: 1339-1341. (Pubitemid 26346934)
31. Jones AE, Shapiro NI, Trzeciak S, et al: Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: A randomized clinical trial. JAMA 2010; 303: 739-746